Koers Immunotech Laboratories, Inc. Other OTC
Aandelen
IMMB
US45254F2039
Biotechnologie & Medisch Onderzoek
Omzet * | - | Omzet 1 * | - | Marktkapitalisatie | 57,5K 52,96K |
---|---|---|---|---|---|
Nettowinst (verlies) * | - | Nettowinst (verlies) 1 * | - | EV/omzet * | - |
Nettoliquiditeiten * | - 0 | Nettoliquiditeiten 1 * | - 0 | EV/omzet 1 * | - |
K/w-verhouding * |
-
| K/w-verhouding 1 * |
-
| Werknemers | - |
Dividendrendement * |
-
| Dividendrendement 1 * |
-
| Vrij verhandelbaar | 99,34% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Director/Board Member | 59 | 04-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,58% | 115 mld. | |
+12,41% | 106 mld. | |
-2,59% | 21,96 mld. | |
-12,38% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-3,35% | 18,08 mld. | |
-38,57% | 17,71 mld. | |
+7,51% | 14,32 mld. | |
+35,67% | 12,42 mld. |